Mitochondria-associated endoplasmic reticulum membrane (MAM): a dark horse for diabetic cardiomyopathy treatment
Abstract Diabetic cardiomyopathy (DCM), an important complication of diabetes mellitus (DM), is one of the most serious chronic heart diseases and has become a major cause of heart failure worldwide. At present, the pathogenesis of DCM is unclear, and there is still a lack of effective therapeutics....
Main Authors: | Yong Liu, Jin-Ling Huo, Kaidi Ren, Shaokang Pan, Hengdao Liu, Yifeng Zheng, Jingfang Chen, Yingjin Qiao, Yang Yang, Qi Feng |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2024-03-01
|
Series: | Cell Death Discovery |
Online Access: | https://doi.org/10.1038/s41420-024-01918-3 |
Similar Items
-
Editorial: Recent advances in mitochondria-associated endoplasmic reticulum membranes (MAMs) in heart-related diseases
by: Yang Yang, et al.
Published: (2023-03-01) -
The contribution of mitochondria-associated endoplasmic reticulum membranes (MAMs) dysfunction in Alzheimer’s disease and the potential countermeasure
by: Zehui Li, et al.
Published: (2023-03-01) -
Mitochondria-associated endoplasmic reticulum membranes (MAMs): Possible therapeutic targets in heart failure
by: Yu Zhang, et al.
Published: (2023-01-01) -
Mitochondria-Associated endoplasmic reticulum Membranes (MAMs) microenvironment: targeting autophagic and apoptotic pathways in cancer therapy
by: Simone ePatergnani, et al.
Published: (2015-07-01) -
Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Is a Promising Signature to Predict Prognosis and Therapies for Hepatocellular Carcinoma (HCC)
by: Yuyan Chen, et al.
Published: (2023-02-01)